231 related articles for article (PubMed ID: 8137681)
21. Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.
Mathiesen ER; Feldt-Rasmussen B; Hommel E; Deckert T; Parving HH
Diabetes Care; 1997 Mar; 20(3):286-9. PubMed ID: 9051373
[TBL] [Abstract][Full Text] [Related]
22. Rate of progression of albuminuria in type II diabetes. Five-year prospective study from south India.
John L; Rao PS; Kanagasabapathy AS
Diabetes Care; 1994 Aug; 17(8):888-90. PubMed ID: 7956637
[TBL] [Abstract][Full Text] [Related]
23. Glycemic control and prognosis in type I diabetic patients with microalbuminuria.
Bojestig M; Arnqvist HJ; Karlberg BE; Ludvigsson J
Diabetes Care; 1996 Apr; 19(4):313-7. PubMed ID: 8729152
[TBL] [Abstract][Full Text] [Related]
24. Exercise testing as a long-term predictor of the development of microalbuminuria in normoalbuminuric IDDM patients.
O'Brien SF; Watts GF; Powrie JK; Shaw KM
Diabetes Care; 1995 Dec; 18(12):1602-5. PubMed ID: 8722059
[TBL] [Abstract][Full Text] [Related]
25. Prediction of persistent microalbuminuria in patients with diabetes mellitus.
Bach LA; Gilbert RE; Cooper ME; Tsalamandris C; Jerums G
J Diabetes Complications; 1993; 7(2):67-72. PubMed ID: 8518458
[TBL] [Abstract][Full Text] [Related]
26. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919
[TBL] [Abstract][Full Text] [Related]
27. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
Chiarelli F; Verrotti A; Mohn A; Morgese G
Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
[TBL] [Abstract][Full Text] [Related]
28. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
[TBL] [Abstract][Full Text] [Related]
29. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
[TBL] [Abstract][Full Text] [Related]
30. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
[TBL] [Abstract][Full Text] [Related]
31. Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.
Diabetes Res Clin Pract; 1997 Nov; 38(2):129-37. PubMed ID: 9483377
[TBL] [Abstract][Full Text] [Related]
32. Progression of borderline increases in albuminuria in adolescents with insulin-dependent diabetes mellitus.
Couper JJ; Clarke CF; Byrne GC; Jones TW; Donaghue KC; Nairn J; Boyce D; Russell M; Stephens M; Raymond J; Bates DJ; McCaul K
Diabet Med; 1997 Sep; 14(9):766-71. PubMed ID: 9300227
[TBL] [Abstract][Full Text] [Related]
33. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?
Nielsen LR; Damm P; Mathiesen ER
Diabetes Care; 2009 Jan; 32(1):38-44. PubMed ID: 18945922
[TBL] [Abstract][Full Text] [Related]
34. Near-normal urinary albumin concentrations predict progression to diabetic nephropathy in Type 1 diabetes mellitus.
Royal College of Physicians of Edinburgh Diabetes Register Group.
Diabet Med; 2000 Nov; 17(11):782-91. PubMed ID: 11131103
[TBL] [Abstract][Full Text] [Related]
35. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?
Mogensen CE
Diabetes; 1990 Jul; 39(7):761-7. PubMed ID: 2191882
[TBL] [Abstract][Full Text] [Related]
36. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study.
Lindhardt M; Persson F; Zürbig P; Stalmach A; Mischak H; de Zeeuw D; Lambers Heerspink H; Klein R; Orchard T; Porta M; Fuller J; Bilous R; Chaturvedi N; Parving HH; Rossing P
Nephrol Dial Transplant; 2017 Nov; 32(11):1866-1873. PubMed ID: 27507891
[TBL] [Abstract][Full Text] [Related]
37. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
38. Does microalbuminuria predict diabetic nephropathy?
Tabaei BP; Al-Kassab AS; Ilag LL; Zawacki CM; Herman WH
Diabetes Care; 2001 Sep; 24(9):1560-6. PubMed ID: 11522699
[TBL] [Abstract][Full Text] [Related]
39. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
Chiarelli F; Catino M; Tumini S; de Martino M; Mezzetti A; Verrotti A; Vanelli M
Diabetes Care; 1999 Jul; 22(7):1158-64. PubMed ID: 10388982
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
Gall MA; Hougaard P; Borch-Johnsen K; Parving HH
BMJ; 1997 Mar; 314(7083):783-8. PubMed ID: 9080995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
